BR9808784A - Método para o tratamento de doença mental em mamìferos e uma composição para o mesmo - Google Patents
Método para o tratamento de doença mental em mamìferos e uma composição para o mesmoInfo
- Publication number
- BR9808784A BR9808784A BR9808784-3A BR9808784A BR9808784A BR 9808784 A BR9808784 A BR 9808784A BR 9808784 A BR9808784 A BR 9808784A BR 9808784 A BR9808784 A BR 9808784A
- Authority
- BR
- Brazil
- Prior art keywords
- mammals
- treatment
- composition
- same
- mental illness
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
<B>MéTODO PARA O TRATAMENTO DE DOENçA MENTAL EM MAMìFEROS E UMA COMPOSIçãO PARA O MESMO<D> A invenção refere-se a um método para tratar um mamífero que sofra de doença mental induzida por propagação de tensão. O referido método compreende a etapa de remover ou diminuir o tono dos adrenoceptores-alfa-2C endógenos no sistema nervoso central do referido mamífero. A invenção refere-se ainda a composições farmacêuticas úteis para o referido tratamento.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US08/854,730 US5902807A (en) | 1997-05-12 | 1997-05-12 | Method for the treatment of mental illness in mammals and a composition therefor |
| PCT/FI1998/000398 WO1998051310A1 (en) | 1997-05-12 | 1998-05-11 | A method for the treatment of mental illness in mammals and a composition therefor |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR9808784A true BR9808784A (pt) | 2000-08-01 |
Family
ID=25319419
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR9808784-3A BR9808784A (pt) | 1997-05-12 | 1998-05-11 | Método para o tratamento de doença mental em mamìferos e uma composição para o mesmo |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US5902807A (pt) |
| EP (1) | EP1003518A1 (pt) |
| JP (1) | JP2001524979A (pt) |
| AU (1) | AU744096B2 (pt) |
| BR (1) | BR9808784A (pt) |
| CA (1) | CA2288650C (pt) |
| EE (1) | EE03667B1 (pt) |
| HU (1) | HUP0002346A3 (pt) |
| NO (1) | NO995469D0 (pt) |
| PL (1) | PL336771A1 (pt) |
| SK (1) | SK154199A3 (pt) |
| WO (1) | WO1998051310A1 (pt) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6593324B2 (en) * | 2000-03-01 | 2003-07-15 | Orion Corporation | Dervatives of quinoline as alpha-2 antagonists |
| JP2003048831A (ja) * | 2001-08-02 | 2003-02-21 | Suntory Ltd | 脳機能の低下に起因する症状あるいは疾患の予防又は改善作用を有する組成物 |
| DE10138275A1 (de) * | 2001-08-10 | 2003-02-27 | Boehringer Ingelheim Pharma | Verbindungen zur Beseitigung der Anhedonie |
| AU2003219199A1 (en) * | 2002-04-03 | 2003-10-13 | Orion Corporation | Use of an alfa2-adrenoreceptor antagonist for cns-related diseases |
| DE60316672T2 (de) * | 2002-04-03 | 2008-07-17 | Orion Corp. | Polycyclische verbindungen als potente alpha2-adrenoceptor antagonisten |
| KR101195574B1 (ko) * | 2002-09-24 | 2012-10-30 | 산토리 홀딩스 가부시키가이샤 | 아라키돈산을 단독으로 또는 도코사헥사엔산과의 조합으로함유하는 인지 능력 향상용 조성물 |
| JP4522075B2 (ja) * | 2003-10-29 | 2010-08-11 | サントリーホールディングス株式会社 | 血管の老化に起因する症状あるいは疾患の予防又は改善作用を有する組成物 |
| JP4993852B2 (ja) | 2004-09-17 | 2012-08-08 | サントリーホールディングス株式会社 | ストレスに起因する行動異常を伴う症状あるいは疾患の予防又は改善作用を有する組成物 |
| JP2006083136A (ja) * | 2004-09-17 | 2006-03-30 | Suntory Ltd | ストレスに起因する脳機能の低下およびそれに伴う症状あるいは疾患の予防又は改善作用を有する組成物 |
| JP5697293B2 (ja) * | 2005-06-30 | 2015-04-08 | サントリーホールディングス株式会社 | 器質的脳障害に起因する高次脳機能の低下に対する改善作用を有する組成物 |
| JP5967855B2 (ja) * | 2005-06-30 | 2016-08-10 | サントリーホールディングス株式会社 | 日中活動量の低下および／又はうつ症状の改善作用を有する組成物 |
| EP3593797A1 (en) * | 2006-12-28 | 2020-01-15 | Suntory Holdings Limited | Nerve-regenerating agent |
| TWI457122B (zh) * | 2007-07-20 | 2014-10-21 | Orion Corp | 作為用於治療周邊和中央神經系統疾病之alpha2C拮抗劑的2,3－二氫苯並[1,4]戴奧辛－2－基甲基衍生物 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3274579B2 (ja) * | 1995-01-12 | 2002-04-15 | 住友製薬株式会社 | 脳血管障害に伴う精神症候治療剤 |
-
1997
- 1997-05-12 US US08/854,730 patent/US5902807A/en not_active Expired - Fee Related
-
1998
- 1998-05-11 HU HU0002346A patent/HUP0002346A3/hu unknown
- 1998-05-11 AU AU74334/98A patent/AU744096B2/en not_active Ceased
- 1998-05-11 BR BR9808784-3A patent/BR9808784A/pt not_active IP Right Cessation
- 1998-05-11 SK SK1541-99A patent/SK154199A3/sk unknown
- 1998-05-11 PL PL98336771A patent/PL336771A1/xx unknown
- 1998-05-11 JP JP54883698A patent/JP2001524979A/ja active Pending
- 1998-05-11 WO PCT/FI1998/000398 patent/WO1998051310A1/en not_active Ceased
- 1998-05-11 EP EP98921508A patent/EP1003518A1/en not_active Withdrawn
- 1998-05-11 CA CA002288650A patent/CA2288650C/en not_active Expired - Fee Related
- 1998-05-11 EE EEP199900561A patent/EE03667B1/xx not_active IP Right Cessation
-
1999
- 1999-11-08 NO NO995469A patent/NO995469D0/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| AU7433498A (en) | 1998-12-08 |
| HUP0002346A1 (hu) | 2001-05-28 |
| NO995469L (no) | 1999-11-08 |
| WO1998051310A1 (en) | 1998-11-19 |
| CA2288650C (en) | 2007-09-25 |
| SK154199A3 (en) | 2001-01-18 |
| NO995469D0 (no) | 1999-11-08 |
| HUP0002346A3 (en) | 2001-09-28 |
| CA2288650A1 (en) | 1998-11-19 |
| PL336771A1 (en) | 2000-07-17 |
| EP1003518A1 (en) | 2000-05-31 |
| JP2001524979A (ja) | 2001-12-04 |
| AU744096B2 (en) | 2002-02-14 |
| US5902807A (en) | 1999-05-11 |
| EE03667B1 (et) | 2002-04-15 |
| EE9900561A (et) | 2000-06-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR9808784A (pt) | Método para o tratamento de doença mental em mamìferos e uma composição para o mesmo | |
| BR0112799A (pt) | Composição farmacêutica, processo para preparação e utilização da mesma, conjunto e processo para tratamento de obesidade, utilização de um inibidor de lìpase e de um sequestrante de ácido de bìlis e processo de tratamento ou prevencão de efeitos colaterais gastrointestinais | |
| DE69815090D1 (de) | Verwendung von cholinesterasehemmer zur behandlung von konzentrationsstörungen | |
| BR9809115A (pt) | Métodos para tratar inflamação e doenças inflamatórias usando inibidores de padprt | |
| BRPI0006634B8 (pt) | composição tópica compreendendo extrato de matricária no tratamento e prevenção de distúrbios inflamatórios | |
| NO961326D0 (no) | Inhibitorer av | |
| BR9811556A (pt) | Terapia de combinação compreendendo atorvastatina e um agente anti-hipertensivo | |
| BRPI0407993A (pt) | inibidores de p38 e métodos para uso dos mesmos | |
| SE9803710D0 (sv) | Use of certain drugs for treating nerve root injury | |
| DK0858330T3 (da) | Præparater indeholdende derivater af hydroperoxyeicosatetraensyre og fremgangsmåder til anvendelse ved behandling af sygdom | |
| BR9916486A (pt) | Combinações de inibidores do transporte de ácidos biliares no ìleo e inibidores da proteìna de transferência do ester colesteril para indicações cardiovasculares | |
| DE69616375D1 (de) | Nicht-allosterische GABA A Agonisten zur Behandlung von Schlafstörungen | |
| BR0111601A (pt) | Método para o tratamento de doença cardiovascular | |
| ATE324908T1 (de) | Verwendung von anti-rubeola antkörpern zur behandlung von symptomen von erkrankungen des zentralen nervensystems | |
| IS5765A (is) | Taugavarnarsamsetning til að fyrirbyggja og/eða meðhöndla tauga- og atferlisbreytingar vegna kvíða ástands og þunglyndis | |
| ATE554169T1 (de) | Smad7-inhibitoren zur behandlung von krankheiten des zns | |
| ATE260653T1 (de) | Verwendung von naaladase inhibitoren zur behandlung von angstzuständen und gedächtnisstörungen | |
| WO2002039994A3 (en) | Methods for the treatment and prevention of urinary stone disease | |
| BR0309406A (pt) | Composição farmacêutica, processo de preparação, kit e métodos para tratamento de obesidade, utilização de composição e inibidor de lìpases, inibidor de lìpáses e glucomanan ou konjac e utilização dos mesmos e método de tratamento | |
| ATE214272T1 (de) | Topische verwendung von kappa- opioidrezeptoragonisten zur behandlung von augenschmerz | |
| ID18382A (id) | Komposisi sediaan farmasi dan metoda pengobatan gangguan kompulsif dengan menggunakan inhibitor naaladase | |
| BR9809678A (pt) | Derivados de triptolìdeo úteis no tratamento de doenças autoimunes | |
| ATE541565T1 (de) | Topische verwendung von muskarinischen und opioiden mitteln zur behandlung von tinnitus | |
| ATE526980T1 (de) | Zusammensetzungen und verfahren zur heilung von nervengeweben | |
| DE59710517D1 (de) | Adamantanaminenderivate zur bekämpfung von viren der familie bornaviridae |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B25A | Requested transfer of rights approved |
Free format text: ORION CORPORATION (FI), OY JUVANTIA PHARMA LTD (FI) |
|
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 8A E 9 ANUIDADES. |
|
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 1912 DE 28/08/2007. |